JPMorgan Chase & Co’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,058,899
| Closed | -$36.4M | – | 5321 |
|
|
2020
Q3 | $36.4M | Buy |
1,058,899
+905,466
| +590% | +$31.1M | 0.01% | 1018 |
|
|
2020
Q2 | $2.56M | Buy |
153,433
+50,144
| +49% | +$838K | ﹤0.01% | 2544 |
|
|
2020
Q1 | $1.49M | Sell |
103,289
-15,411
| -13% | -$222K | ﹤0.01% | 2744 |
|
|
2019
Q4 | $3.97M | Sell |
118,700
-10,015
| -8% | -$335K | ﹤0.01% | 2313 |
|
|
2019
Q3 | $2.7M | Buy |
128,715
+6,787
| +6% | +$142K | ﹤0.01% | 2572 |
|
|
2019
Q2 | $2.43M | Sell |
121,928
-6,706
| -5% | -$134K | ﹤0.01% | 2564 |
|
|
2019
Q1 | $2.88M | Sell |
128,634
-16,952
| -12% | -$379K | ﹤0.01% | 2442 |
|
|
2018
Q4 | $3.48M | Sell |
145,586
-380
| -0.3% | -$9.09K | ﹤0.01% | 2321 |
|
|
2018
Q3 | $3.98M | Buy |
145,966
+9,289
| +7% | +$253K | ﹤0.01% | 2377 |
|
|
2018
Q2 | $3.68M | Sell |
136,677
-6,074
| -4% | -$163K | ﹤0.01% | 2442 |
|
|
2018
Q1 | $4.54M | Sell |
142,751
-18,858
| -12% | -$600K | ﹤0.01% | 2269 |
|
|
2017
Q4 | $6.11M | Sell |
161,609
-132,796
| -45% | -$5.02M | ﹤0.01% | 2117 |
|
|
2017
Q3 | $7.24M | Sell |
294,405
-48,352
| -14% | -$1.19M | ﹤0.01% | 1956 |
|
|
2017
Q2 | $7.05M | Buy |
342,757
+79,225
| +30% | +$1.63M | ﹤0.01% | 1933 |
|
|
2017
Q1 | $5.73M | Sell |
263,532
-32,655
| -11% | -$710K | ﹤0.01% | 2022 |
|
|
2016
Q4 | $6.06M | Buy |
296,187
+113,537
| +62% | +$2.32M | ﹤0.01% | 1998 |
|
|
2016
Q3 | $2.74M | Buy |
182,650
+76,675
| +72% | +$1.15M | ﹤0.01% | 2308 |
|
|
2016
Q2 | $1.15M | Buy |
105,975
+63,675
| +151% | +$689K | ﹤0.01% | 2703 |
|
|
2016
Q1 | $574K | Buy |
+42,300
| New | +$574K | ﹤0.01% | 2882 |
|